Production & Manufacturing
Production & Manufacturing
Merus Labs acquires Emselex/Enablex drug rights in Canada, Europe
Specialty pharmaceutical company, Merus Labs International, has acquired Emselex/Enablex (darifenacin) extended release tablets rights from Novartis Pharma in Canada and Europe, excluding France, Spain and Italy. As part of the acquisition, Merus Labs will...
Production & Manufacturing
Xcellerex launches new bag-type XDR-10 single-use bioreactor
Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor. The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l....
Production & Manufacturing
Clarity Pharmaceuticals, Dalton Pharma sign manufacturing services contract
Dalton Pharma Services has entered into a Manufacturing Services contract with Clarity Pharmaceutical. Under the agreement Clarity's PET based companion diagnostics and radio-immunotherapeutics development program will receive cGMP chemistry manufacturing,scale up and aseptic fill/finish...
Production & Manufacturing
ADIENNE Pharma signs manufacturing deal with Selexis
ADIENNE Pharma & Biotech has signed a service agreement with Selexis for the development of a manufacturing cell line for one of the ADIENNE's orphan drugs. Selexis CEO Igor Fisch said, "Combining our expertise...
Production & Manufacturing
Indian state plans non-generic drugs procurement for government hospitals
Indian state of Uttar Pradesh is planning to procure non-generic drugs directly from the manufacturing companies for usage in government hospitals in the state. The state government is formulating a new drug policy that...
Production & Manufacturing
Natco Pharma wins license to manufacture, sell Nexavar in India
The Indian patents office has awarded a license to Natco Pharma to manufacture and sell a generic version of Bayer's cancer treatment drug Nexavar. As per the Indian Patents Act, Natco Pharma will be...
Production & Manufacturing
BioLife Solutions to build second GMP production facility
BioLife Solutions has executed an amendment to its current commercial lease to double the area of its existing facilities. The additional space will be used to the build a second GMP manufacturing clean room...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
